HR5592-118

Introduced

To prohibit the use of Federal funds from preventing a State from implementing their own laws with respect to psilocybin.

118th Congress Introduced Sep 20, 2023

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

This bill, To prohibit the use of Federal funds from preventing a State from implementing their own laws with respect to psilocybin., changes federal law or congressional policy affecting research institutions and space-sector operators. The main policy domain is Science & Space.

Who Benefits and How

research institutions and space-sector operators may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.

Who Bears the Burden and How

federal implementing agencies, research institutions and space-sector operators may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.

Key Provisions

  • Section H15DCF7B4ED9640AB91F18D442A2614A0: 1. Short title This Act may be cited as the Validating Independence for State Initiatives on Organic Natural Substances Act of 2023 or the VISIONS Act of 2023.
  • Section H08D44A0D944241D691EFC9580FE4FBF2: 2. Prohibition on the use of Federal funds with respect to psilocybin No Federal funds may be used to prevent any State or unit of local government from...

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

This bill, To prohibit the use of Federal funds from preventing a State from implementing their own laws with respect to psilocybin., changes federal law or congressional policy affecting research institutions and space-sector operators.

Key Policy Areas

Science & Space

Primary Purpose

This bill, To prohibit the use of Federal funds from preventing a State from implementing their own laws with respect to psilocybin., changes federal law or congressional policy affecting research institutions and space-sector operators.

Policy Domains

Science & Space

Whole bill

Identified Gains
  • research institutions and space-sector operators
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
research institutions and space-sector operators:
Identified Costs
  • federal implementing agencies
  • research institutions and space-sector operators
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
federal implementing agencies:
research institutions and space-sector operators:

Legislative Progress

Introduced
Introduced Committee Passed
Sep 20, 2023

Mr. Robert Garcia of California (for himself and Mr. Blumenauer) …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Science & Space
Actor Mappings
"federal_implementing_agencies"
→ Federal agencies assigned duties by the bill

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology